Literature DB >> 17613599

Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis.

Ralph H B Benedict1, Jared Bruce, Michael G Dwyer, Bianca Weinstock-Guttman, Chris Tjoa, Eleonora Tavazzi, Frederick E Munschauer, Robert Zivadinov.   

Abstract

Following a previous study with diffusion tensor imaging, we investigated the correlation between diffusion-weighted imaging (DWI) and cognitive dysfunction in multiple sclerosis (MS). We studied 60 MS patients (mean age 45.8+/-9.0 years) using 1.5-T MRI. Disease course was RR=40 and SP = 20. Mean disease duration was 12.8+/-8.7 years. Mean EDSS was 3.4+/-1.7. Whole brain, gray and white matter normalized volumes were calculated on 3D SPGR T1-WI using a fully automated Hybrid SIENAX method. Parenchymal mean diffusivity (PMD) maps were created after automated segmentation of the brain parenchyma and cerebrospinal fluid using T2-WI and DW images. Histogram analysis was performed and DWI indices of peak position (PP), peak height (PH), mean parenchymal diffusivity (MPD) and entropy were obtained. Neuropsychological (NP) evaluation emphasized auditory/verbal and visual/spatial memory, as well as processing speed and executive function. We found significant correlations between DWI and performance in all cognitive domains. Overall, stronger correlations emerged for MPD and entropy than other DWI measures, although all correlations were in the expected direction. The strongest association was between DWI entropy and performance on the Symbol Digit Modalities Test, which assesses processing speed and working memory (r = -0.54). Fisher r to z transformations revealed that DWI, gray matter (GMF) and whole brain (BPF) atrophy, T1-lesion volume (LV) and T2-LV all accounted for similar amounts of variance in NP testing. Stepwise regression models determined whether multiple MRI measures predicted unique additive variance in test performance. GMF (R2 = 0.35, F =30.82, P <0.01) and entropy (DeltaR2 =0.06, DeltaF=5.47, P <0.05) both accounted for unique variance in processing speed. Our data make a stronger case for the clinical validity of DWI in MS than heretofore reported. DWI has very short acquisition times, and the segmentation method applied in the present study is reliable and fully automated. Given its overall simplicity and moderate correlation with cognition, DWI may offer several logistic advantages over more traditional MRI measures when predicting the presence of NP impairment.

Entities:  

Mesh:

Year:  2007        PMID: 17613599     DOI: 10.1177/1352458507075592

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  26 in total

Review 1.  Reliability and validity of neuropsychological screening and assessment strategies in MS.

Authors:  Ralph H B Benedict; Robert Zivadinov
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

2.  Normal-appearing white matter permeability distinguishes poor cognitive performance in processing speed and working memory.

Authors:  A Eilaghi; A Kassner; I Sitartchouk; P L Francis; R Jakubovic; A Feinstein; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-30       Impact factor: 3.825

Review 3.  Translational research in neurology and neuroscience 2010: multiple sclerosis.

Authors:  Olaf Stüve; Bernd C Kieseier; Bernhard Hemmer; Hans-Peter Hartung; Amer Awad; Elliot M Frohman; Benjamin M Greenberg; Michael K Racke; Scott S Zamvil; J Theodore Phillips; Ralf Gold; Andrew Chan; Uwe Zettl; Ron Milo; Ellen Marder; Omar Khan; Todd N Eagar
Journal:  Arch Neurol       Date:  2010-07-12

4.  The computer-based Symbol Digit Modalities Test: establishing age-expected performance in healthy controls and evaluation of pediatric MS patients.

Authors:  Sandra Bigi; R A Marrie; C Till; E A Yeh; N Akbar; A Feinstein; B L Banwell
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

5.  MRI predictors of cognitive outcome in early multiple sclerosis.

Authors:  M S A Deloire; A Ruet; D Hamel; M Bonnet; V Dousset; B Brochet
Journal:  Neurology       Date:  2011-03-29       Impact factor: 9.910

6.  Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.

Authors:  Andrew B Rosenkrantz; Michael J Triolo; Jonathan Melamed; Henry Rusinek; Samir S Taneja; Fang-Ming Deng
Journal:  J Magn Reson Imaging       Date:  2014-02-25       Impact factor: 4.813

7.  Composite MRI scores improve correlation with EDSS in multiple sclerosis.

Authors:  A H Poonawalla; S Datta; V Juneja; F Nelson; J S Wolinsky; G Cutter; P A Narayana
Journal:  Mult Scler       Date:  2010-09       Impact factor: 6.312

8.  Greater than age-related changes in brain diffusion of HIV patients after 1 year.

Authors:  Linda Chang; Victoria Wong; Helanna Nakama; Michael Watters; Darlene Ramones; Eric N Miller; Christine Cloak; Thomas Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-15       Impact factor: 4.147

9.  MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis.

Authors:  Milena Stosic; Julian Ambrus; Neeta Garg; Bianca Weinstock-Guttman; Murali Ramanathan; Bernadette Kalman; Alireza Minagar; Frederick E Munschauer; Timothy M Galey; Sara Hussein; Rohit Bakshi; Robert Zivadinov
Journal:  J Neurol       Date:  2009-07-26       Impact factor: 4.849

Review 10.  Ocular motor signatures of cognitive dysfunction in multiple sclerosis.

Authors:  Joanne Fielding; Meaghan Clough; Shin Beh; Lynette Millist; Derek Sears; Ashley N Frohman; Nathaniel Lizak; Jayne Lim; Scott Kolbe; Robert L Rennaker; Teresa C Frohman; Owen B White; Elliot M Frohman
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.